Skip to content
healthcare.dev

GUANFACINE

NDC 46708-745, GUANFACINE, tablet, extended release, from Alembic Pharmaceuticals Limited.

Product NDC
46708-745
Status
Listed
Labeler
Alembic Pharmaceuticals Limited
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217269
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/46708-745 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUANFACINE HYDROCHLORIDE1 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
46708-745-3146708074531100 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-745-31)
46708-745-91467080745911000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-745-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/983b3157-cbea-435d-ba32-9ee7ef95226a

Use it

Look up 46708-745 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/46708-745 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 46708-745. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.